Public Company News

K. A. Prabhakaran Appointed Senior Vice President and Chief Technology Officer of Cyient

HYDERABAD, India and DALLAS, March 10, 2025 /PRNewswire/ -- Cyient Limited, a global Intelligent Engineering solutions company, announced the appointment of K. A. Prabhakaran as Senior Vice President and Chief Technology Officer of its DET business. Prabhakaran is an accomplished professional in...

2025-03-10 21:15 2446

World's First Large-Scale, Multicenter Prospective Study in Single-Reading Mammography Confirms Lunit AI Boosts Cancer Detection

Prospective study finds Lunit AI increases cancer detection by 13.8% in single-reader settings without raising recall rates, presenting a game-changing tool for countries relying on single-reader mammography screening SEOUL, South Korea, March 10, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a le...

2025-03-10 21:00 3099

Agora Launches Conversational AI Toolkit for IoT Devices

New partnerships with Beken and Robopoet showcase the future of interactive toys and connected devices SANTA CLARA, Calif., March 10, 2025 /PRNewswire/ -- Agora, Inc. (NASDAQ: API), a global leader in real-time engagement solutions, is expanding into AI-powered robotics and interactive toys with...

2025-03-10 21:00 2577

Visionary Takes the Lead in the New Energy Vehicle Field and Builds an Innovative Industrial Ecosystem

TORONTO, March 10, 2025 /PRNewswire/ -- Recently, Visionary announced that it will make a major foray into the new energy vehicle industry and build a unique integrated industrial ecosystem of "vehicle-station-power-cloud-research-finance". It is committed to creating a new industry landscape in...

2025-03-10 21:00 4150

CBAK Energy to Report fourth quarter & full year 2024 Unaudited Financial Results on Monday, March 17, 2025

DALIAN, China, March 10, 2025 /PRNewswire/ -- CBAK Energy Technology, Inc. (NASDAQ: CBAT) ("CBAK Energy", or the "Company"), a leading lithium-ion battery manufacturer and electric energy solution provider in China, today announced that it will report its unaudited financial results for the fourt...

2025-03-10 21:00 3166

NYSE Content advisory: Pre-market update for March 10th

NEW YORK, March 10, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content advisory: Pre-market update for March 10...

2025-03-10 20:57 3367

NYSE CONTENT ADVISORY: New York Stock Exchange Partnership Network Update

NEW YORK, March 10, 2025 /PRNewswire/ -- At the inaugural New York Stock Exchange Partnership Day, the NYSE put out a call to action by bringing together leading media partners, publishers, ad tech leaders, content creators, agencies, and platforms to launch the NYSE Partnership Network. Here is ...

2025-03-10 20:50 3511

SunCar Wins Contract to Build Insurance Platform for Major EV Maker Leapmotor

NEW YORK, March 10, 2025 /PRNewswire/ -- SunCar Technology Group Inc. ("SunCar" or the "Company") (NASDAQ: SDA), an innovative leader in auto e-insurance and cloud-based B2B auto services inChina, today announced it has secured a contract to develop and operate the insurance management platform f...

2025-03-10 20:45 3761

Kelun-Biotech's TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) Approved for Marketing in Second Indication by NMPA for EGFRm NSCLC

CHENGDU, China, March 10, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company's trophoblast cell-surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, formerly SKB264/MK-2870) was approved ...

2025-03-10 19:22 2550

Mitsubishi Motors Canada Launches AI-Powered "Intelligent Companion" to Transform the 2025 Outlander Buying Experience

LONDON, ARMONK, N.Y. and MISSISSAUGA, ON, March 10, 2025 /PRNewswire/ -- Mitsubishi Motor Sales ofCanada  announces an innovative AI-powered tool designed to transform the customer experience for the new Mitsubishi Outlander 2025. "The Intelligent Companion <...

2025-03-10 19:00 2449

Yum China Appoints Adrian Ding as Chief Financial Officer

SHANGHAI, March 10, 2025 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China") (NYSE: YUMC and HKEX: 9987) announced that after a thorough search process,Adrian Ding has been appointed as Chief Financial Officer, effective onMarch 6, 2025. Adrian has been serving as Acting Chief...

2025-03-10 18:30 3513

XCMG Certified Pre-Owned Crawler Cranes Deployed in Southeast Asia to Support Large-Scale Infrastructure Projects

NAYPYIDAW, Myanmar, March 10, 2025 /PRNewswire/ -- XCMG Machinery ("XCMG", SHE: 000425), a global leader in construction equipment manufacturing, has successfully delivered a batch of XCMG Certified Pre-Owned Crawler Cranes, models XGC85 and XGC55, to support major infrastructure projects inSouth...

2025-03-10 18:19 5031

ChipMOS REPORTS FEBRUARY 2025 REVENUE

HSINCHU, March 10, 2025 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange:8150 and Nasdaq: IMOS), an industry leading provider of outsourced semiconductor assembly and test services ("OSAT")...

2025-03-10 18:00 3590

Taiyo Oil Selects Honeywell Ethanol To Jet Technology For Production Of Sustainable Aviation Fuel

Production in Okinawa, Japan to be the first in Asia Pacific, targeting 200 million liters of ETJ SAF annually TOKYO, March 10, 2025 /PRNewswire/ -- Honeywell (NASDAQ: HON) today announced that Taiyo Oil Co., Ltd. has chosen the Honeywell UOP Ethanol to Jet (ETJ) technology to produce Sustainabl...

2025-03-10 16:58 3026

Lundbeck's potential treatment for Multiple System Atrophy granted Orphan Drug Designation in Japan

VALBY, Denmark, March 10, 2025 /PRNewswire/ -- The Ministry of Health, Labor, and Welfare (MHLW) inJapan has granted Orphan Drug Designation (ODD) to Lundbeck's investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA). H. Lundbeck A/S (Lundbeck) a...

2025-03-10 16:57 2343

Pioneer Insurance Selects Sapiens to Drive Digital Innovation in the Philippines

Sapiens Insurance Platform for P&C supports Pioneer's broad digital strategy and ability to scale quickly and cost-effectively UXBRIDGE, England, March 10, 2025 /PRNewswire/ -- Sapiens International Corporation (NASDAQ: SPNS) (TASE: SPNS), a leading global provider of s...

2025-03-10 15:15 4084

The Ritz-Carlton, Bali Voted as "Best Indonesia Resort" in DestinAsian Readers' Choice Awards 2025

BALI, Indonesia, March 10, 2025 /PRNewswire/ -- The Ritz-Carlton, Bali was voted the Best Indonesia Resort (Ranked No.1) in the2025 DestinAsian Readers' Choice Awards . This prestigious recognition showcase...

2025-03-10 13:22 3198

HD Hyundai Executive Vice Chairman Chung Kisun meets with Palantir CEO Alex Karp to discuss 'AI Shipyard'

SEOUL, South Korea, March 9, 2025 /PRNewswire/ -- HD Hyundai Executive Vice ChairmanChung Kisun met with Palantir Technologies Inc. CEO Alex Karp to discuss the project on building AI shipyards.

2025-03-10 11:02 3966

AIM Vaccine's Iteratively Upgraded Diploid Rabies Vaccine Approved for Clinical Trials, Showing Significantly Higher Efficacy than Marketed Diploid Rabies Vaccines

HONG KONG, March 10, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement onMarch 9, 2025, the company's research and development of a diploid rabies vaccine has recently received the Clinical Trial Approval Notice from the National Medic...

2025-03-10 08:00 4203

U.S. FDA approves Celltrion's OMLYCLO® (omalizumab-igec) as the first and only biosimilar with interchangeability designation referencing XOLAIR®

* OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by theFDA * Regulatory approval for interchangeability was supported by positive phase III data demonstrating comparable efficacy and safety profile with the reference product XOLAIR® (omalizumab)[1] * The ava...

2025-03-10 07:16 3611

Week's Top Stories